Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
Frontiers in Immunology
|
June 2, 2023
Efficacy of ICI-based treatment in advanced NSCLC patients with PD-L1≥50% who developed EGFR-TKI resistance
Yujing Li, Haohua Jiang, Fangfei Qian, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
August 27, 2010
A46G and C79G polymorphisms in the β2-adrenergic receptor gene (ADRB2) and essential hypertension risk: a meta-analysis
Yuqing Lou, Jinghua Liu, Yan Huang, et al.
Plos One
|
January 5, 2012
A-6G and A-20C polymorphisms in the angiotensinogen promoter and hypertension risk in Chinese: a meta-analysis
Wei Gu, Jielin Liu, Qiuli Niu, et al.
Thoracic Cancer
|
March 7, 2020
Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?
Yuqing Lou, Runbo Zhong, Jianlin Xu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 16, 2013
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis
Yuqing Lou, Rong Li, Liwen Xiong, et al.
Frontiers in Oncology
|
December 6, 2021
The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus
Jie Qian, Weimin Wang, Lin Wang, et al.
Frontiers in Oncology
|
October 2, 2019
Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
Jun Lu, Qin Shi, Lele Zhang, et al.
Oncotargets and Therapy
|
July 2, 2020
Expression Level of Wnt5a Was Related to the Therapeutic Effects of First-Generation EGFR-TKIs
Hai Zhang, Xiaohua Yang, Fang Hu, et al.
Frontiers in Immunology
|
October 4, 2021
<i>TP53</i> Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer
Jun Lu, Runbo Zhong, Yuqing Lou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2016
EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China
Jianlin Xu, Bo Jin, Tianqing Chu, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
Frontiers in Immunology
|
June 2, 2023
Efficacy of ICI-based treatment in advanced NSCLC patients with PD-L1≥50% who developed EGFR-TKI resistance
Yujing Li, Haohua Jiang, Fangfei Qian, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
August 27, 2010
A46G and C79G polymorphisms in the β2-adrenergic receptor gene (ADRB2) and essential hypertension risk: a meta-analysis
Yuqing Lou, Jinghua Liu, Yan Huang, et al.
Plos One
|
January 5, 2012
A-6G and A-20C polymorphisms in the angiotensinogen promoter and hypertension risk in Chinese: a meta-analysis
Wei Gu, Jielin Liu, Qiuli Niu, et al.
Thoracic Cancer
|
March 7, 2020
Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?
Yuqing Lou, Runbo Zhong, Jianlin Xu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 16, 2013
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis
Yuqing Lou, Rong Li, Liwen Xiong, et al.
Frontiers in Oncology
|
December 6, 2021
The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus
Jie Qian, Weimin Wang, Lin Wang, et al.
Frontiers in Oncology
|
October 2, 2019
Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
Jun Lu, Qin Shi, Lele Zhang, et al.
Oncotargets and Therapy
|
July 2, 2020
Expression Level of Wnt5a Was Related to the Therapeutic Effects of First-Generation EGFR-TKIs
Hai Zhang, Xiaohua Yang, Fang Hu, et al.
Frontiers in Immunology
|
October 4, 2021
<i>TP53</i> Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer
Jun Lu, Runbo Zhong, Yuqing Lou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2016
EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China
Jianlin Xu, Bo Jin, Tianqing Chu, et al.
Page
of 12